RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FRANCISCI D
Collezione ASL Città di Torino

Items : 16

Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people with HIV from the STOPSHIV cohort. in AIDS (London, England) / AIDS. 2025 Feb 1;39(2):143-152. doi: 10.1097/QAD.0000000000004042. Epub 2024 Oct 21.

2025
ASL Città di Torino

De Socio GV; Ricci E; Piconi S; Squillace N; Maggi P; Orofino G; Altobelli D; Santoro C; Guastavigna M; Menzaghi B; Salomoni E; Di Biagio A; dell'Omo M; Francisci D; Bonfanti P;

Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade. in HIV medicine / HIV Med. 2022 Jan;23(1):70-79. doi: 10.1111/hiv.13165. Epub 2021 Sep 2.

2022
ASL Città di Torino

Taramasso L; Bonfanti P; Ricci E; Maggi P; Orofino G; Squillace N; Menzaghi B; Madeddu G; Molteni C; Vichi F; Riguccini E; Saracino A; Santoro C; Guastavigna M; Francisci D; Di Biagio A; De Socio GV;

Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020. in Scientific reports / Sci Rep. 2022 Apr 6;12(1):5736. doi: 10.1038/s41598-022-09738-0.

2022
ASL Città di Torino

Andreoni M; Mastroianni CM; Nunnari G; Babudieri S; Schiavo R; Orsi A; Caucci S; Cerutti F; Menozzi I; Cirillo D; Tonon G; Miola A; Vicenti I; Francisci D; Callegaro A; Sagnelli C; Brindicci G; Sarmati L; Antonelli G; Rullo EV; Fiore V; Codeluppi M; Bruzzone B; Menzo S; Ghisetti V; Morganti M; Toppo S; Bergna A; Lai A; et alii...

Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021. in Virology journal / Virol J. 2021 Aug 14;18(1):168. doi: 10.1186/s12985-021-01638-5.

2021
ASL Città di Torino

Lai A; Bergna A; Menzo S; Zehender G; Caucci S; Ghisetti V; Rizzo F; Maggi F; Cerutti F; Giurato G; Weisz A; Turchi C; Bruzzone B; Ceccherini Silberstein F; Clementi N; Callegaro A; Sagradi F; Francisci D; Venanzi Rullo E; Vicenti I; Clementi M; Galli M;

Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study. in BMC public health / BMC Public Health. 2020 May 20;20(1):734. doi: 10.1186/s12889-020-08862-8.

2020
ASL Città di Torino

De Socio GV; Pasqualini M; Ricci E; Maggi P; Orofino G; Squillace N; Menzaghi B; Madeddu G; Taramasso L; Francisci D; Bonfanti P; Vichi F; dell'Omo M; Pieroni L;

Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort. in AIDS research and human retroviruses / AIDS Res Hum Retroviruses. 2020 Jan;36(1):19-26. doi: 10.1089/AID.2019.0115. Epub 2019 Oct 8.

2020
ASL Città di Torino

De Socio GV; Maggi P; Ricci E; Orofino G; Squillace N; Menzaghi B; Madeddu G; Di Biagio A; Francisci D; Bonfanti P; Vichi F; Schiaroli E; Santoro C; Guastavigna M; dell'Omo M;

Is It Feasible to Impact on Smoking Habits in HIV-Infected Patients? Mission Impossible From the STOPSHIV Project Cohort. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2020 Apr 15;83(5):496-503. doi: 10.1097/QAI.0000000000002284.

2020
ASL Città di Torino

De Socio GV; Ricci E; Maggi P; Orofino G; Squillace N; Menzaghi B; Madeddu G; Di Biagio A; Francisci D; Bonfanti P; Vichi F; dell'Omo M;

Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2019 Nov;25(11):1443-1446. doi: 10.1016/j.cmi.2019.07.004. Epub 2019 Jul 25.

2019
ASL Città di Torino
AOU Novara

Monno L; Callegaro AP; Paolini E; Zoncada A; Pecorari M; Francisci D; Borghi V; Galli L; Vicenti I; Bruzzone B; Taramasso L; Ungaro R; Bonora S; Di Biagio A;

The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2019 May 1;81(1):e17-e21. doi: 10.1097/QAI.0000000000001986.

2019
ASL Città di Torino

Rossetti B; Gagliardini R; Sterrantino G; Colangeli V; Latini A; Colafigli M; Vignale F; Rusconi S; Di Biagio A; Orofino G; Mezzaroma I; Vullo V; Francisci D; Mastroianni C; Trezzi M; Canovari B; Lamonica S; Ciccullo A; Borghetti A; D?Arminio Monforte A; Di Giambenedetto S; De Luca A;

Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study. in BMC infectious diseases / BMC Infect Dis. 2019 Jun 25;19(1):555. doi: 10.1186/s12879-019-4184-z.

2019
ASL Città di Torino

Maggi P; Santoro CR; Nofri M; Ricci E; De Gennaro N; Bellacosa C; Schiaroli E; Orofino G; Menzaghi B; Di Biagio A; Squillace N; Francisci D; Vichi F; Molteni C; Bonfanti P; Gaeta GB; De Socio GV;

Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Jul 1;73(7):1955-1964. doi: 10.1093/jac/dky123.

2018
ASL Città di Torino

Fabbiani M; Gagliardini R; Ciccarelli N; Quiros Roldan E; Latini A; d'Ettorre G; Antinori A; Castagna A; Orofino G; Francisci D; Chinello P; Madeddu G; Grima P; Rusconi S; Del Pin B; Lombardi F; D'Avino A; Focà E; Colafigli M; Cauda R; Di Giambenedetto S; De Luca A;

Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc. in International journal of STD & AIDS / Int J STD AIDS. 2017 Oct;28(11):1067-1073. doi: 10.1177/0956462416687828. Epub 2017 Jan 31.

2017
ASL Città di Torino

Dentone C; Sterrantino G; Signori A; Cenderello G; Guerra M; De Leo P; Bartolacci V; Mantia E; Orofino G; Giacomini M; Bruzzone B; Francisci D; Di Biagio A;

Treatment simplification to atazanavir/ritonavir?+?lamivudine versus maintenance of atazanavir/ritonavir?+?two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M). in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Apr 1;72(4):1163-1171. doi: 10.1093/jac/dkw557.

2017
ASL Città di Torino

Di Giambenedetto S; Fabbiani M; Quiros Roldan E; Latini A; D'Ettorre G; Antinori A; Castagna A; Orofino G; Francisci D; Chinello P; Madeddu G; Grima P; Rusconi S; Di Pietro M; Mondi A; Ciccarelli N; Borghetti A; Focà E; Colafigli M; De Luca A; Cauda R;

Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial. in PloS one / PLoS One. 2017 Nov 21;12(11):e0187393. doi: 10.1371/journal.pone.0187393. eCollection 2017.

2017
ASL Città di Torino

Rossetti B; Gagliardini R; Meini G; Sterrantino G; Colangeli V; Re MC; Latini A; Colafigli M; Vignale F; Rusconi S; Micheli V; Di Biagio A; Orofino G; Ghisetti V; Fantauzzi A; Vullo V; Grima P; Francisci D; Mastroianni C; Antinori A; Trezzi M; Lisi L; Navarra P; Canovari B; D'Arminio Monforte A; Lamonica S; D'Avino A; Zazzi M; Di Giambenedetto S; et alii...

Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19818. doi: 10.7448/IAS.17.4.19818. eCollection 2014.

2014
ASL Città di Torino

Gagliardini R; Rossetti B; Bianco C; Rusconi S; Colafigli M; Prinapori R; Francisci D; Fantauzzi A; Orofino G; Vignale F; Di Giambenedetto S; De Luca A;

Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19808. doi: 10.7448/IAS.17.4.19808. eCollection 2014.

2014
ASL Città di Torino

Fabbiani M; Di Giambenedetto S; Quiros-Roldan E; Latini A; Vullo V; Antinori A; Castagna A; Orofino G; Francisci D; Grilli E; Madeddu G; Grima P; Rusconi S; Del Pin B; Mondi A; Borghetti A; Focà E; Colafigli M; De Luca A; Cauda R;